Fellows will receive a competitive salary along with comprehensive medical, dental, vision benefits.
Additional Information:
Employer will assist with relocation costs.
Internal Number: #7203A
About Alexion
Alexion, AstraZeneca’s Rare Disease group, was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. For more than 30 years, Alexion’s mission has been to transform the lives of people affected by rare diseases through the development and delivery of innovative medicines as well as supportive technologies and healthcare services. Dedicated to continuing its mission as part of AstraZeneca, Alexion leads with the knowledge that patients and caregivers are people first, and by seeking to understand their experiences, Alexion is better able to serve their unique needs.
Alexion’s pioneering legacy in rare diseases is rooted in being the first to translate the complex biology of the complement system into novel medicines. Alexion continues to push the boundaries of science to accelerate the discovery and development of new life-changing medicines for even more people affected by rare diseases. Headquartered in Boston, Massachusetts, Alexion has offices around the globe and continues to expand its reach to benefit the lives of more rare disease patients around the world.
MCPHS in collaboration with Alexion, AstraZeneca Rare Disease is offering fellowship experience within Global Value, Access, and Pricing (GVAP) with an enriched Health Economics & Outcomes research (HEOR) experience.
Astrazeneca’s Rare Disease GVAP team is seeking a fellow to be part of a dynamic and growing team working in the metabolic portfolio. This is a strategic role leveraging your understanding and application of global healthcare, HTA system knowledge, competitive insights, and clinical background to shape market access, pricing and reimbursement success for critical product launches and indications.
This fellowship provides a unique opportunity to develop an expertise in the cross-section of GVAP & HEOR. Global market access and health economics are complimentary functions with HTA/payers as the core stakeholder and this fellowship is designed to combine the strategic components of HEOR and apply them to real-world global market access problems. As a fellow you will learn to lead the development and execution of value, access, and price strategies for launch assets to support patient access to our medicines. As key parts of the development team, we help shape the clinical development program, develop value propositions that help inform evidence generation activities, and establish pricing recommendations for products in our portfolio.
Value, Access, and Pricing Focused Objectives:
Support development of differentiated target product profile that fulfills cross stakeholder needs aligned to robust value proposition
Develop global pricing and reimbursement (P&R) strategies and framework in close collaboration with launch and program teams
Creation and roll out of value, and access communication tools and materials to support local P&R submissions and negotiations
Cultivate understanding of global health care, HTA systems, and latest developing trends especially within rare disease
Health Economics and Outcomes Research Focused Objectives:
Comprehensive understanding of what evidence payers value across market/payer archetypes
Fundamentals of economic modeling bridging to appreciation of level of evidence needed from payer perspective
Influencing trial design, outcomes, and endpoint strategy to support payer needs
Exposure to different methodologies to quantify and fill evidence gaps including burden of disease & unmet need
To be considered for an interview, please complete a fellowship application on the MCPHS SMApply application portal. Visit https://mcphs.smapply.io/
Please DO NOT request an interview within PPS. Our recruitment teams will contact qualified candidates via email to schedule interviews.
The MCPHS application portal (SMApply) will open up on Monday, October 7, 2024. Applicants must upload the following application materials to the online portal by Monday, November 4, 2024:
Letter of intent (addressed to the company specific program director/lead; found in each company brochure)
Curriculum vitae
Unofficial college transcript
Contact information for three references. References will receive an electronic recommendation form to complete separately.
Three recommendation evaluation forms must be submitted no later than November 20, 2024 via the online portal. This is NOT a letter of recommendation but an online form that the recommender will receive for completion from SMApply.
Application Review and Interview Timeline
Following a review of submitted applications, pre-screens and preliminary interviews will begin in October. Additional interviews, including final rounds will take place in December during ASHP. Candidates will be notified if selected for an interview. The process is rigorous and competitive; therefore candidates should submit their applications well in advance of posted deadlines as priority will be given to those who apply early.
ASHP Midyear and Onsite Interviews
The fellowship program will be conducting in-person interviews at the ASHP Midyear Clinical Meeting in New Orleans, LA. Attendance is strongly encouraged, but not required. Candidates attending in-person will not be able to interview without registering for both ASHP and PPS. Please refer to the ASHP & PPS website for registration details.
Top candidates may be invited for interviews at the sponsoring company’s location
AIFA First Offer Date
The choice of a Post-Doctoral Fellowship is an important decision. MCPHS, in conjunction with the Alliance of Industry Fellowship Associates (AIFA), has aligned to extend offers for Fellowships no earlier than December 16, 2024. We believe this is a positive reflection of the cultures our Programs offer, and that culture is a critical consideration in choice of Fellowship. We hope that other academic and non-academic Fellowship Programs will NOT pressure candidates to accept offers prior to this aligned offer date.
We see this respect for candidate choice as a common aspect of each of our Program's cultures. We hope that other academic and non-academic Fellowship Programs will respect this timeline.
The MCPHS Biopharmaceutical Industry fellows will be selected on a nationally competitive basis. Applicants must have a Doctor of Pharmacy degree from an ACPE accredited college of pharmacy at the commencement of the program.
Candidates must have strong written and verbal communication skills and a strong interest in pursuing a career within the biopharmaceutical industry.
All candidates must have authorization to work in the United States throughout the duration of the one or two year fellowship. No visa sponsorship will be provided (i.e., TN, H-1B, STEM OPT, etc.).
Onboarding
Final candidates will be required to go through additional screening / onboarding as required by MCPHS
Alexion, AstraZeneca’s Rare Disease group, was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. For more than 30 years, Alexion’s mission has been to transform the lives of people affected by rare diseases through the development and delivery of innovative medicines as well as supportive technologies and healthcare services. Dedicated to continuing its mission as part of AstraZeneca, Alexion leads with the knowledge that patients and caregivers are people first, and by seeking to understand their experiences, Alexion is better able to serve their unique needs.
Alexion’s pioneering legacy in rare diseases is rooted in being the first to translate the complex biology of the complement system into novel medicines. Alexion continues to push the boundaries of science to accelerate the discovery and development of new life-changing medicines for even more people affected by rare diseases. Headquartered in Boston, Massachusetts, Alexion has offices around the globe and continues to expand its reach to benefit the lives of more rare disease patients around the world.
MCPHS provides an academic environment to guide and support fellows toward a successful career ...in the biopharmaceutical industry. As a private institution with a history of specializing in health sciences, MCPHS offers programs that embody scholarship, professional service, and community outreach.
Through MCPHS, the fellow will have the opportunity to gain teaching and research experience in an academic setting. MCPHS faculty and company program leaders mentor fellows according to their scholarly and professional interests throughout the two-year program.
As an adjunct instructor at MCPHS, the fellow may have the opportunity to: develop, coordinate, and teach courses; co-precept pharmacy students on advanced experiential rotations; create and publish scholarly research and/or review articles; present research at scientific and clinical meetings; participate in professional development seminars with other fellows and residents from MCPHS-affiliated programs.